Propiedad y actividad de insiders de Evaxion Biotech A/S (EVAX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $3.03 |
| Capitalización | $19M |
| Bolsa | NASDAQ |
| País | DK |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $468000 | $7.4M | $9.6M | $5.8M | $32.2M | $13.2M | $5.6M | $5.1M | $23.2M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $2.1M | $772000 | 0 | 0 | 0 | 0 | 0 | $1.9M | $1.1M |
| Inventario | 0 | -$1.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $2.7M | $8.4M | $11.0M | $10.9M | $34.7M | $17.0M | $8.3M | $8.8M | $24.9M |
| Inmovilizado Material | $213000 | $130000 | $101000 | $221000 | $5.2M | $4.7M | $4.3M | $3.5M | $3.3M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $100000 | $93000 | 0 | 0 | 0 | 0 |
| Activos Totales | $2.9M | $8.5M | $11.1M | $12.0M | $40.2M | $22.0M | $12.9M | $12.5M | $28.4M |
| Cuentas por Pagar | $59000 | $139000 | $646000 | $3.7M | $2.8M | $2.1M | $2.7M | $3.0M | $2.2M |
| Deuda a Corto | 0 | $8.6M | 0 | 0 | $126000 | $136000 | $159000 | $159000 | $190000 |
| Pasivos Corrientes | $303000 | $9.4M | $1.7M | $4.9M | $4.3M | $3.8M | $7.1M | $4.4M | $4.3M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $1.0M | $7.9M | $8.5M | $8.0M | $5.3M |
| Pasivos Totales | $399000 | $9.4M | $1.7M | $4.9M | $7.7M | $13.7M | $17.6M | $14.1M | $11.4M |
| Reservas | -$3.5M | -$7.0M | -$15.8M | -$27.3M | -$50.4M | -$85.8M | -$108.0M | -$118.5M | -$126.2M |
| Patrimonio Neto | $2.5M | -$931000 | $9.4M | $7.0M | $32.4M | $8.3M | -$4.7M | -$1.7M | $17.0M |
| Deuda Total | $162000 | $8.7M | $36000 | $20000 | $3.7M | $10.3M | $10.9M | $10.1M | $7.5M |
| Deuda Neta | -$306000 | $1.2M | -$9.5M | -$5.8M | -$28.5M | -$2.9M | $5.3M | $5.0M | -$15.7M |
| Capital Circulante | $2.4M | -$1.0M | $9.2M | $6.0M | $30.4M | $13.2M | $1.3M | $4.4M | $20.6M |
Salud financiera
| Deuda / Patrimonio | 0.75 |
| Ratio corriente | 5.06 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -4.54 |
Rentabilidad
| Rentabilidad sobre capital | -45.23% |
| Rentabilidad sobre capital invertido | -33.44% |
| Rentabilidad sobre activos | -27.13% |
| Margen bruto | 100.00% |
| Margen operativo | -115.98% |
| Margen neto | -115.49% |
Empresas relacionadas: ANVS · BCAB · BTAI · CELU · GBIO · MURA · PYPD
Explorar sector: Healthcare · Biotechnology
Más secciones de EVAX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones